Cargando…
Chloroquine: Autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check?
The recent SARS-CoV-2 pandemic poses one of the greatest challenges to modern medicine. Therefore, identification of new therapeutic strategies seems essential either based on novel vaccines or drugs or simply repurposing existing drugs. Notably, due to their known safety profile, repurposing of exi...
Autores principales: | Sharma, Pawan, McAlinden, Kielan D., Ghavami, Saeid, Deshpande, Deepak A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857018/ https://www.ncbi.nlm.nih.gov/pubmed/33545161 http://dx.doi.org/10.1016/j.ejphar.2021.173928 |
Ejemplares similares
-
Chloroquine and COVID-19: role as a bitter taste receptor agonist?
por: Bouazza, B., et al.
Publicado: (2021) -
Bitter Taste Receptor Agonists Mitigate Features of Allergic Asthma in Mice
por: Sharma, Pawan, et al.
Publicado: (2017) -
Bitter Taste Receptors for Asthma Therapeutics
por: Nayak, Ajay P., et al.
Publicado: (2019) -
There can be smoke without fire: warranted caution in promoting electronic cigarettes and heat not burn devices as a safer alternative to cigarette smoking
por: McAlinden, Kielan Darcy, et al.
Publicado: (2019) -
Chemoinformatics View on Bitter Taste Receptor Agonists
in Food
por: Bayer, Sebastian, et al.
Publicado: (2021)